| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute coronary syndrome in patients with hemophilia: a delicate balancing act
|
Mayfield, Jacob J.
|
|
|
54 |
2 |
p. 323-329
|
artikel
|
| 2 |
Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series
|
Bradshaw, Paige Garber
|
|
|
54 |
2 |
p. 295-300
|
artikel
|
| 3 |
Association of the careggi collateral score with radiological outcomes after thrombectomy for stroke with an occlusion of the middle cerebral artery
|
Cappellari, Manuel
|
|
|
54 |
2 |
p. 309-317
|
artikel
|
| 4 |
Conservative treatment vs thrombus removal for Iliofemoral vein thrombosis in patients with congenital abnormalities of the inferior vena cava: a case report and systematic review of the literature
|
Alexiou, Vangelis G.
|
|
|
54 |
2 |
p. 230-254
|
artikel
|
| 5 |
Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy
|
Chen, Jingshi
|
|
|
54 |
2 |
p. 260-267
|
artikel
|
| 6 |
Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism
|
Novak, Alison R.
|
|
|
54 |
2 |
p. 276-286
|
artikel
|
| 7 |
High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19
|
Bray, Monica
|
|
|
54 |
2 |
p. 211-216
|
artikel
|
| 8 |
Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors
|
Alma, Stancu
|
|
|
54 |
2 |
p. 287-294
|
artikel
|
| 9 |
Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports
|
Koh, Ming-Yi
|
|
|
54 |
2 |
p. 339-349
|
artikel
|
| 10 |
Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type
|
Ames, Paul R. J.
|
|
|
54 |
2 |
p. 330-338
|
artikel
|
| 11 |
Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection
|
Shiuan, Eileen
|
|
|
54 |
2 |
p. 367-371
|
artikel
|
| 12 |
Metformin therapy in COVID-19: inhibition of NETosis
|
Kow, Chia Siang
|
|
|
54 |
2 |
p. 217-218
|
artikel
|
| 13 |
Oseltamivir as rescue therapy for persistent, chronic, or refractory immune thrombocytopenia: a case series and review of the literature
|
Colunga-Pedraza, Perla R.
|
|
|
54 |
2 |
p. 360-366
|
artikel
|
| 14 |
Pharmacosimulation of delays and interruptions during administration of tirofiban: a systematic comparison between EU and US dosage regimens
|
Heramvand, Nadia
|
|
|
54 |
2 |
p. 301-308
|
artikel
|
| 15 |
Pre-admission antithrombotic use is associated with 3-month mRS score after thrombectomy for acute ischemic stroke
|
Krieger, Penina
|
|
|
54 |
2 |
p. 350-359
|
artikel
|
| 16 |
Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell’s viper venom time and silica clotting time increases thrombotic risk prediction
|
Lee, Youngeun
|
|
|
54 |
2 |
p. 318-322
|
artikel
|
| 17 |
Real world prescribing practices of apixaban or rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patients
|
Williams, Matthew
|
|
|
54 |
2 |
p. 219-229
|
artikel
|
| 18 |
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement
|
Virk, Zain M.
|
|
|
54 |
2 |
p. 255-259
|
artikel
|
| 19 |
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
|
Barnes, Geoffrey D
|
|
|
54 |
2 |
p. 197-210
|
artikel
|
| 20 |
Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate
|
Kjerengtroen, Sara
|
|
|
54 |
2 |
p. 268-275
|
artikel
|
Tijdschrift beschrijving